Related Experiment Video
Updated: Jun 6, 2026

A Comparative Approach to Characterize the Landscape of Host-Pathogen Protein-Protein Interactions
Published on: July 18, 2013
GPR35 in host-microbe interaction: Mechanisms and translational prospects
Jian Chen1, Xiaoying Cai1, Qingyun Ma1
1State Key Laboratory of Natural Medicines, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China; Laboratory of Metabolic Regulation and Drug Target Discovery, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
Abstract:
Understanding the mechanism of host-microbe interaction expands the landscape of drug discovery. Challenges, however, exist in the discovery of druggable targets from their signaling network. G protein-coupled receptors are versatile sensors at the host-microbe interface, and G protein-coupled receptor 35 (GPR35) is increasingly shown to play a role via metabolic, immune, and neural mechanisms. These advances not only enrich the pharmacology of this orphan receptor but also suggest an alternative path for microbiome-based therapeutics. We update the knowledge on GPR35-mediated host-microbe interaction in health and disease. We discuss the need to probe endogenous ligands of GPR35 with pathophysiological and human relevance, highlighting the complexities from species selectivity and signaling bias. We also propose potential strategies to translate the emerging insights into therapeutics with a balanced efficacy and safety profile.
Insights
G protein-coupled receptor 35 (GPR35) is a key target for microbiome therapeutics, influencing host health through metabolic, immune, and neural pathways. Further research into its ligands could unlock new drug discovery avenues.
Area of Science:
- Host-microbe interactions
- Pharmacology
- Drug discovery
Background:
- Host-microbe interactions are crucial for understanding disease and developing new therapeutics.
- G protein-coupled receptors (GPCRs) act as sensors at the host-microbe interface.
- G protein-coupled receptor 35 (GPR35) is an orphan receptor implicated in metabolic, immune, and neural functions.
Purpose of the Study:
- To review current knowledge on GPR35-mediated host-microbe interactions in health and disease.
- To highlight the potential of GPR35 as a target for microbiome-based therapeutics.
- To discuss challenges and propose strategies for GPR35 drug discovery.
Main Methods:
- Literature review and knowledge update on GPR35 function.
- Analysis of GPR35's role in host-microbe signaling pathways.
- Discussion of therapeutic translation strategies.
Main Results:
- GPR35 plays a significant role in host-microbe interactions across metabolic, immune, and neural systems.
- Advances in GPR35 pharmacology suggest its potential for microbiome-based therapies.
- Challenges include identifying relevant endogenous ligands and managing species selectivity and signaling bias.
Conclusions:
- GPR35 represents a promising target for developing novel microbiome-based therapeutics.
- Further investigation into GPR35's endogenous ligands is necessary for clinical translation.
- Strategies are needed to ensure balanced efficacy and safety in GPR35-targeted therapies.
More Related Videos
Related Concept Videos
Transduction
Microorganisms in Medicine and Therapeutics
Gene Regulation in Microbial Communities: Quorum Sensing
Translational Regulation
Leaky Scanning
Colonisation of Pathogens

